New Year Sale Saxagliptin Hcl, Dpp-iv Inhibitor (tbi4076) Shop The Look [2KD6MNsz]

Saxagliptin HCl, DPP-IV Inhibitor

Introducing our premium Saxagliptin HCl, a highly effective DPP-IV inhibitor designed for the treatment of diabetes. This innovative compound, known by the alternate name BMS-477118, boasts a molecular formula of C₁₈H₂₅N₃O₂·HCl and a formula weight of 416.40. With a purity of greater than 98%, this product is a reliable choice for medical professionals and researchers alike. The key features of Saxagliptin HCl include its high selectivity for DPP-IV, with a Ki value of 0.6 nM, and its ability to dissolve in DMSO, making it versatile for various applications.

Product Specifications

Saxagliptin HCl comes in the form of a fine powder, suitable for a wide range of experiments and treatments. This compound is highly stable and maintains its effectiveness for at least one year when stored at -20°C. The solubility of Saxagliptin HCl in DMSO is exceptional, allowing for concentrations up to 20 mg/ml. With these specifications, our product is designed to meet the rigorous demands of pharmaceutical research and clinical applications.

• Purity: >98%
• Formulation: Powder
• Solubility: Soluble in DMSO (up to 20 mg/ml)
• Storage: -20°C
• Stability: ≥ 1 year

Applications and Benefits

Saxagliptin HCl is a valuable tool in the fight against diabetes, offering a clinically proven solution for managing blood glucose levels. Its exceptional human DPP-IV inhibitory activity makes it a preferred choice in the pharmaceutical industry. Whether used in research or clinical settings, this product provides numerous benefits, including improved patient outcomes and enhanced treatment efficacy. Ideal for both laboratory research and therapeutic applications, Saxagliptin HCl is a must-have for anyone involved in the diabetes treatment field.

• Diabetes Management: Effective in lowering blood glucose levels
• Research Tool: Ideal for studying DPP-IV inhibition and its effects on glucose metabolism
• Therapeutic Application: Aids in the development of new diabetes treatments